| | | | | |
AGIO Agios Pharmaceuticals, Inc. | $28,8850 | +4,35 % | $1,74B | $122,14K | |
SGRY Surgery Partners, Inc. Common Stock | $13,7950 | +2,11 % | $1,74B | $379,73K | |
GAB The Gabelli Equity Trust Inc. | $5,5950 | -0,27 % | $1,74B | $555,60K | |
HURN Huron Consulting Group Inc. | $107,69 | +2,75 % | $1,74B | $25,11K | |
ENVX Enovix Corporation Common Stock | $8,3020 | +0,88 % | $1,74B | $2,75M | |
PAYO Payoneer Global Inc. Common Stock | $5,2050 | +2,26 % | $1,74B | $1,10M | |
ETV Eaton Vance Tax-Managed Buy-Write Opportunities Fund | $14,9200 | +0,07 % | $1,73B | $66,39K | |
STGW Stagwell Inc. Class A Common Stock | $6,7550 | +2,50 % | $1,73B | $295,73K | |
CASH Pathward Financial, Inc. Common Stock | $78,8770 | +1,46 % | $1,73B | $55,35K | |
SNDX Syndax Pharmaceuticals, Inc. | $17,9210 | -2,28 % | $1,73B | $4,48M | |
STRA Strategic Education, Inc. Common Stock | $81,5350 | +3,14 % | $1,73B | $67,72K | |
CAPR Capricor Therapeutics Inc | $28,2800 | +2,32 % | $1,73B | $164,16K | |
AAPG Ascentage Pharma Group International American Depository Shares | $18,4190 | +3,07 % | $1,73B | $1,72K | |
SLS SELLAS Life Sciences Group, Inc. Common Stock | $8,8650 | +8,24 % | $1,73B | $3,49M | |
PLSE Pulse Biosciences, Inc Common Stock (DE) | $27,5450 | +10,22 % | $1,73B | $279,86K | |
